First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Breast cancer vaccine endpoints met with 74% immune response
Lilly to build $6bn Alabama facility
Base to Base biotech podcast 36: Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI
SAS Clinical Acceleration debuts to modernise clinical trials and accelerate time to market
China’s first AI drug completes phase III trial
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
Ryght AI and Biorasi to partner on AI
Novel gene therapy for ALS cleared for trials in US and China
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations